Characterization of long-term survivors with metastatic uveal melanoma and liver metastases diagnosed between 2005 and 2021
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Patients with metastatic uveal melanoma (UM) have a poor prognosis. Liver metastases occur in more than 90% of cases and are the main determinant of life expectancy [1] [2]. Immune checkpoint inhibitors (ICI) are less effective in UM than in cutaneous melanoma (CM). Therefore, liver-directed therapies are of high relevance. Although there are promising long-term survival data in CM, such data are lacking in UM and long-term survivors are rare.
Source: EJC Skin Cancer
Authors: J. Laukhuf, L. Wiens, G. Grözinger, H. Dittmann, K. Thiel, U. Leiter, T. Amaral, L. Nanz, L. Flatz, M. Reitmajer, A. Forschner
Institution: Universitätsklinikum Tübingen
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,340
OpenAlex ID: W4409116854